Hologic Inc. (NASDAQ:HOLX) saw a downside of -0.83% to $80.92 after subtracting -$0.67 on Wednesday. The 5-day average trading volume is 1,683,591 shares of the company’s common stock. It has gained $81.72 in the past week and touched a new high 4 times within the past 5 days. An average of 1,673,393 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,515,579.
HOLX’s 1-month performance is 8.18% or $5.42 on its low of $74.06 reached on 12/30/22. The company’s shares have touched a 52-week low of $59.78 and high of $81.97, with the stock’s rally to the 52-week high happening on 01/09/23. YTD, HOLX has achieved 9.06% or $6.12 and has reached a new high 4 times. However, the current price is down -1.29% from the 52-week high price.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
HOLX stock investors last saw insider trading activity on Dec 14.Hellmann Elisabeth A (SVP, Human Resources) most recently sold 1,649 shares at $76.40 per share on Dec 14. This transaction cost the insider $125,984. Chairman, President and CEO, MACMILLAN STEPHEN P, sold 33,500 shares at a price of $75.65 on Nov 30. Then, on Nov 15, Group Pres, Global Diagnostics Thornal Kevin R sold 19,118 shares at a price of $75.32 per share. This transaction amounted to $1,440,062.
HOLX stock has a beta of 1.02. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 4.08 while the price-to-book (PB) in the most recent quarter is 4.19, with the price to cash flow ratio at 9.58.
Hologic Inc.’s quick ratio for the period ended September 29 was 3.50, with the current ratio over the same period at 4.10. As well, the company’s long term debt to equity for the quarter ending September 29 was 0.58, while the total debt to equity was 0.58. In terms of profitability, the gross margin trailing 12 months is 62.00%. The firm’s gross profit as reported stood at $3.0 billion against revenue of $4.86 billion.
For the quarterly period ending September 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income shrunk -17.38% to $228.4 million, while revenue of $455.7 million was -99.52% off the previous quarter. Analysts expected HOLX to announce $0.62 per share in earnings in its latest quarter, but it posted $0.82, representing a 32.30% surprise. EBITDA for the quarter stood at more than $247.5 million. HOLX stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 4.2 billion, with total debt at $2.92 billion. Shareholders hold equity totaling $245.83 million.
Let’s look briefly at Hologic Inc. (HOLX) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 24 January was 63.82% to suggest the stock is trending Neutral, with historical volatility in this time period at 17.61%.
The stock’s 5-day moving average is $80.51, reflecting a +2.55% or $2.01 change from its current price. HOLX is currently trading +7.18% above its 20-day SMA, +19.79% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +7.91% and SMA200 by+1.84%.
Stochastic %K and %D was 90.22% and 84.06% and the average true range (ATR) pointed at 1.55. The RSI (14) points at 63.26%, while the 14-day stochastic is at 81.23% with the period’s ATR at 1.60. The stock’s 9-day MACD Oscillator is pointing at 1.30 and 1.55 on the 14-day charts.
In the most recent analyst report for Hologic Inc. (NASDAQ: HOLX), RBC Capital Mkts launched coverage with a Sector perform rating. Analysts offering their rating for HOLX stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate HOLX as a “sell,”, while 11 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 2 rates the stock as overweight while 8 have offered a “buy” rating.
What is HOLX’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $67.80 and a high of $91.00, with their median price target at $85.50. Looking at these predictions, the average price target given by analysts is for Hologic Inc. (HOLX) stock is $82.99.